Thrombosis Research
Volume 127, Supplement 3 , Pages S51-S52, February 2011

APS – controversies in diagnosis and management, critical overview of current guidelines

  • Vittorio Pengo

      Affiliations

    • Corresponding Author InformationCorrespondence: Vittorio Pengo M.D. Clinical Cardiology, Thrombosis Center, Dept. of Cardiac Thoracic and Vascular Sciences, Via Giustiniani 2, 35128 Padova, Italy. Tel.:+390498215658; fax: +390498215658

Clinical Cardiology, Thrombosis Center, University of Padova School of Medicine, Padova, Italy

Abstract 

Because the diagnosis of antiphospholipid syndrome is based on laboratory data, performance and interpretation of such tests is essential. Positivity in a single test among Lupus Anticoagulant (LA), anti cardiolipin (aCL) and anti β2-glycoprotein I (aβ2GPI) antibodies calls APS diagnosis into question. Conversely, triple positivity is strongly associated to thrombosis and pregnancy morbidity. A new era in studying APS should take into account different antiphospholipid antibodies profiles. Clinical studies on groups of patients that are homogeneous in terms of laboratory tests will provide information on the real risk of patients and on the real effect of therapeutic interventions.

Keywords:  Antiphospholipid syndrome (APS) , Diagnosis , Patient laboratory profile , Therapeutic interventions

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0049-3848(11)70014-7

doi:10.1016/S0049-3848(11)70014-7

Thrombosis Research
Volume 127, Supplement 3 , Pages S51-S52, February 2011